Insights On Enterprise Solutions

  1. The Environmental Case For Single-Use Systems 11/3/2026

    Plastic waste is easy to see, but the water, steam, and energy used to clean reusable equipment between batches may carry the larger burden. A life cycle comparison tests that.

  2. Advances In ADC Development And Manufacturing 11/3/2026

    ADC manufacturability starts at molecule design, not downstream rescue. Learn how operator exposure to high-potency payloads shapes how conjugation workflows are built and qualified.

  3. The People Behind The Process: How Teams Enable Flexible Manufacturing 11/2/2026

    Biopharma demands flexibility across specialty and high-volume products. The right equipment, automation, and teams enable partners to pivot without compromising quality.

  4. Lonza Capabilities Update October 2026: Large Molecule 11/2/2026

    Ben Neunstoecklin, Director of Commercial Development, provides an overview of biologics drug substance manufacturing capabilities and global network capacity that supports customer programs from development through commercial supply.

  5. Lonza Capabilities Update October 2026: Fill/Finish 11/2/2026

    Bastian Klöfer, Director of Commercial Development, Drug Product Services, explores Lonza's end-to-end biologics network, spanning drug substance, drug product development, manufacturing, analytics and regulatory support.

  6. What Integrated Biologics Look Like In Practice 11/2/2026

    Integrating biopharmaceutical development and manufacturing within a regional network accelerates clinical progress, strengthens compliance, and enhances supply chain resilience.

  7. Global Biophorum Leaders In Poland 11/2/2026

    Peer collaboration and facility visits drive operational excellence, continuous quality improvement, and stronger supply chains across biopharmaceutical development.

     

  8. From Powder To Robust Tablet With Less Material: Compaction Simulator Arrives At Ardena Ghent 10/29/2026

    Advanced compaction simulation predicts formulation performance and tablet strength with minimal material, streamlining scale-up and accelerating development to clinical manufacturing.

  9. A Four-Step Framework For Building A Biomarker Strategy 10/29/2026

    A strong biomarker strategy starts with the right clinical questions, analytical platforms, and early context-of-use planning to support efficient, successful drug development.

  10. Collaborating For Supply Chain Resilience 10/28/2026

    Cell culture media supply resilience shapes continuity. A global CDMO's approach to tariff exposure spans both proprietary formulations and standard media, showing how supply strategy holds up.